Literature DB >> 15691236

Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand.

Nitipatana Chierakul1, Praphat Wongwisutikul, Sasijit Vejbaesya, Kannikar Chotvilaiwan.   

Abstract

OBJECTIVE: Susceptibility to COPD is, in part, genetically determined. Tumour necrosis factor (TNF)-alpha gene promoter polymorphisms have been investigated in different populations with inconsistent results. This study aimed to determine the genetic predisposition in Thai smoking-related COPD patients.
METHODOLOGY: The polymorphism at position -308 of the TNF-alpha gene promoter was examined in 57 patients with smoking-related COPD, 67 smoker control subjects, and 116 control anonymous blood donors. Genomic DNA from peripheral blood lymphocytes was used for genotypic analysis by polymerase chain reaction with sequence specific primers.
RESULTS: TNF-alpha-308*2 allele frequency was not significantly different between the population control subjects and the smoking-related COPD patients (4.7% vs. 7.9%, P= 0.14). This allele frequency was also not significantly different between smokers with and without COPD (7.9% vs. 7.5%, P= 0.46).
CONCLUSIONS: Although it has been speculated that TNF-alpha might have a causal relationship with COPD, a role for the TNF-alpha gene promoter polymorphism in disease development in Thailand was not demonstrated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15691236     DOI: 10.1111/j.1440-1843.2005.00626.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  12 in total

1.  Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease.

Authors:  Yung-Che Chen; Shih-Feng Liu; Chien-Hung Chin; Chao-Chien Wu; Chung-Jen Chen; Hsueh-Wen Chang; Yi-Hsi Wang; Yu-Hsiu Chung; Tung-Ying Chao; Meng-Chih Lin
Journal:  Lung       Date:  2010-03-30       Impact factor: 2.584

2.  TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects.

Authors:  Ping Zhan; Jing Wang; Shu-Zhen Wei; Qian Qian; Li-Xin Qiu; Li-Ke Yu; Yong Song
Journal:  Mol Biol Rep       Date:  2010-04-04       Impact factor: 2.316

3.  Transforming growth factor-β1 and tumor necrosis factor-α are associated with clinical severity and airflow limitation of COPD in an additive manner.

Authors:  Chi-Huei Chiang; Chiao-Hui Chuang; Shiou-Ling Liu
Journal:  Lung       Date:  2013-10-24       Impact factor: 2.584

Review 4.  National Emphysema Treatment Trial state of the art: genetics of emphysema.

Authors:  Craig P Hersh; Dawn L DeMeo; Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

5.  Association of cytokine gene polymorphisms in patients with chronic obstructive pulmonary disease.

Authors:  Rajni Kant Shukla; Surya Kant; Sandeep Bhattacharya; Balraj Mittal
Journal:  Oman Med J       Date:  2012-07

Review 6.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18

Review 7.  Role of TNFalpha in pulmonary pathophysiology.

Authors:  Srirupa Mukhopadhyay; John R Hoidal; Tapan K Mukherjee
Journal:  Respir Res       Date:  2006-10-11

8.  Smoking and Alzheimer's disease among Mongolian and Han Chinese aged 55 years and over living in the Inner Mongolia farming area of China.

Authors:  Chunyu Zhang; Lin Da; Shigang Zhao; Desheng Wang; Guangming Niu
Journal:  Neural Regen Res       Date:  2012-07-15       Impact factor: 5.135

9.  A case-control study of tumor necrosis factor-alpha promoter polymorphism and its serum levels in patients with chronic obstructive pulmonary disease in Kashmir, North India.

Authors:  Hyder Mir; Parvaiz Ahmad Koul; Dilafroze Bhat; Zaffar Amin Shah
Journal:  Lung India       Date:  2020 May-Jun

Review 10.  Association between TNF-α -308 G/A polymorphism and COPD susceptibility: a meta-analysis update.

Authors:  Lu Zhang; Hao Gu; Yihang Gu; Xiaoning Zeng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.